NECAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.588000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.482800E-01
Normal-vs-Stage2
7.919800E-01
Normal-vs-Stage3
5.196600E-01
Normal-vs-Stage4
4.842500E-02
Stage1-vs-Stage2
1.582630E-01
Stage1-vs-Stage3
1.028440E-01
Stage1-vs-Stage4
5.145800E-01
Stage2-vs-Stage3
2.434000E-01
Stage2-vs-Stage4
4.284900E-03
Stage3-vs-Stage4
4.295600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.243200E-01
Normal-vs-AfricanAmerican
8.367800E-01
Normal-vs-Asian
6.196600E-01
Caucasian-vs-AfricanAmerican
6.351200E-01
Caucasian-vs-Asian
1.021410E-01
AfricanAmerican-vs-Asian
3.893600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.624200E-01
Normal-vs-Female
6.587200E-01
Male-vs-Female
8.156200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.802400E-01
Normal-vs-Age(41-60Yrs)
4.339400E-01
Normal-vs-Age(61-80Yrs)
7.842600E-01
Normal-vs-Age(81-100Yrs)
9.668000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.434000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.245600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.255200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.057650E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.887880E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.921200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.777000E-01
Normal-vs-Daily Drinker
8.836200E-01
Normal-vs-Weekly Drinker
9.694800E-01
Normal-vs-Occasional Drinker
3.819400E-01
Normal-vs-Social Drinker
4.644200E-01
Non Drinker-vs-Daily Drinker
6.887800E-01
Non Drinker-vs-Weekly Drinker
8.941400E-01
Non Drinker-vs-Occasional Drinker
4.788300E-02
Non Drinker-vs-Social Drinker
1.260830E-01
Daily Drinker-vs-Weekly Drinker
8.659200E-01
Daily Drinker-vs-Occasional Drinker
3.675600E-02
Daily Drinker-vs-Social Drinker
9.764300E-02
Weekly Drinker-vs-Occasional Drinker
8.219700E-02
Weekly Drinker-vs-Social Drinker
1.584790E-01
Occasional Drinker-vs-Social Drinker
6.930800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.370800E-01
Normal-vs-Grade 2
4.763400E-03
Normal-vs-Grade 3
4.678400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.300200E-02
Grade 1-vs-Grade 3
1.676010E-01
Grade 1-vs-Grade 4
1.370800E-01
Grade 2-vs-Grade 3
1.829620E-01
Grade 2-vs-Grade 4
4.763400E-03
Grade 3-vs-Grade 4
4.678400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.376600E-01
Normal-vs-NonDiabetic
6.655800E-01
Diabetic-vs-NonDiabetic
1.601970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.430600E-01
Normal-vs-NoPancreatitis
7.199800E-01
Pancreatitis-vs-NoPancreatitis
7.628200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.694800E-01
Normal-vs-N1
7.584800E-01
N0-vs-N1
9.306300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.035600E-01
Normal-vs-TP53-NonMutant
4.460600E-01
TP53-Mutant-vs-TP53-NonMutant
4.161500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
